Anjali Sergeant[/caption]
Anjali Sergeant
McMaster Medicine Class of 2022
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: This collaborative study from the University of Toronto and McMaster University found that inpatients in the Greater Toronto Area (GTA) cared for by female physicians had lower mortality rates compared to those cared for by male physicians. Specifically, a 0.47% difference in patient deaths was reported, which is significant in the context of thousands of deaths in Ontario hospitals each year. This supports similar findings from an American study (Tsugawa et. al) published in 2017.
Our study also examined gender-based differences in medical practice, including lab and imaging tests ordered, and medications prescribed. Female doctors ordered significantly more imaging tests for their patients but this factor did not explain their lower patient death rates.
The mortality difference shrank when accounting for the number of years that doctors were in practice. This suggests that patients of female doctors may have better outcomes partially because more women make up newer medical grads in Canada, who may be more up-to-date on clinical guidelines.
Dr. Chi-yuan Hsu[/caption]
Chi-yuan Hsu, MD, MSc (he/him/his)
Professor and Division Chief
Division of Nephrology
University of California, San Francisco
San Francisco, CA 94143-0532
MedicalResearch.com: What is the background for this study?
Response: There has been a great deal of controversy recently about how race should be considered in medicine, including its use in estimating kidney function (e.g. https://jamanetwork.com/journals/jama/fullarticle/2769035). A recent paper published in JAMA Network Open by Zelnick et al suggested that removing the race coefficient improves the accuracy of estimating kidney function (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2775076) in the Chronic Renal Insufficiency Cohort, a NIH-funded study (www.cristudy.org).
We are core investigators of the Chronic Renal Insufficiency Cohort Study and were not involved in the Zelnick’s study that was based on a public use dataset. Because we were surprised by the methodological approach they took and the conclusion they came to, we implemented our own analysis of the data.
Dr. Ohl[/caption]
Michael Ohl, MD, MSPH
Associate Professor of Internal Medicine-Infectious Diseases
Roy J. and Lucille A. Carver College of Medicine
University of Iowa
MedicalResearch.com: What is the background for this study?
Response: The background is that remdesivir was approved for treatment in 2020 largely based on the results of the Adaptive COVID-19 Treatment Trial 1 (ACTT-1), which found that remdesivir treatment was associated with more rapid recovery from illness among people hospitalized with COVID-19. The intention was that - even if remdesivir did not lead to substantial improvements in survival- it could help people to recover more quickly and be discharged from hospital sooner, potentially opening scare hospital pends to treat more patients during the pandemic.
Dr. Reza[/caption]
Nosheen Reza, MD, FACC, FHFSA
Assistant Professor of Medicine, Division of Cardiovascular Medicine
Penn Center for Inherited Cardiovascular Disease
Section of Advanced Heart Failure, Transplantation, and Mechanical Support
Hospital of the University of Pennsylvania &
the Perelman School of Medicine at the University of Pennsylvania
MedicalResearch.com: What is the background for this study?
Response: In academic internal medicine in the United States, gender disparities in salary and promotion have been researched and documented for over 20 years. Despite this, in recent years, the number of women pursuing careers in medicine has increased, and now, more women than men are enrolled in U.S. medical schools. We wanted to take a contemporary look at the composition of the U.S. academic internal medicine physician workforce and evaluate the relationships between the representation of women in each internal medicine specialty with their salaries and academic rank.
We hypothesized that even though there may be more women physicians practicing in these specialties compared with prior years, the disparities in academic rank and salary, as compared with men, would still exist.
Dr. Rotenstein[/caption]
Lisa Rotenstein, MD, MBA
Assistant Medical Director
Population Health and Faculty Wellbeing
Department of Medicine
Brigham and Women's Hospital
MedicalResearch.com: What is the background for this study?
Response: Our previous work in JAMA Internal Medicine demonstrated significant differences in time spent on the electronic health record (EHR) by specialty, and specifically showed that primary care clinicians spent significantly more total and after-hours time on the EHR than surgical and medical specialty counterparts. Primary care clinicians spent twice as long as surgical colleagues on notes, and received more than twice as many messages from team-mates, five times as many patient messages, and fifteen times as many prescription messages each day.
Given these findings, the heavy administrative burden placed on primary care clinicians, and previous data about burnout among primary care clinicians, we wanted to better understand differences in time spent on the EHR among the different types of primary care clinicians.
Dr. Margaret Ryan[/caption]
Margaret Ryan MD MPH
Medical Director of Defense Health Agency Immunization
Healthcare Division
Pacific Region Office, San Diego CA
Clinical Professor at the University of California San Diego
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Military clinicians, especially those in the Defense Health Agency Immunization Healthcare Division, first became aware of a few cases of myocarditis following COVID-19 vaccination in early Feb 2021. These cases included young men who presented with chest pain a few days after 2nd dose of mRNA (Pfizer or Moderna) vaccine. As more young people became eligible for 2nd doses of vaccine, more cases were identified. By late April, the military had identified 23 cases of myocarditis, with remarkably similar presentations, after COVID-19 vaccination. This case series is described in the current issue of JAMA Cardiology.
Prof. Schuppan, MD, PhD[/caption]
Prof. Dr. D. Schuppan, MD, PhD
Professor of Medicine
Director Institute of Translational Immunology
University Medical Center of the Johannes Gutenberg University
Consultant Gastroenterologist and Hepatologist
Director Celiac and Small Intestinal Disease Center
Director Center for Food Intolerances and Autoimmunity
Director Liver Fibrosis and Metabolism Research
Research Center for Immune Therapy (FZI)
Mainz Project for Chemical Allergology (MPCA)
Mainz, Germany
Professor of Medicine, Division of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School Boston, MA 02215
MedicalResearch.com: What is the background for this study?
Response: Celiac disease (CeD) is a common intestinal inflammatory disease that affects about 1% of most wheat consuming populations worldwide. CeD is caused by the ingestion of gluten containing foods, such as wheat, spelt, rye and barley, that activate small intestinal inflammatory T cells.
The only current therapy is the rigorous avoidance of even traces of gluten in the daily diet, which is difficult and a social and psychological burden.
We previously identified the body’s own enzyme tissue transglutaminase (TG2) as the CeD autoantigen. Moreover, TG2 drives celiac disease pathogenesis by enzymatically modifying dietary gluten peptides that makes them more immunogenic.
We therefore developed an oral small molecule (ZED1227) that specifically inhibits TG2 activity in the intestine.
While this should attenuate CeD in patients exposed to dietary gluten, it was unclear if it could prevent gluten induced intestinal inflammation and damage.
Dr. Yeghiazarians[/caption]
Yerem Yeghiazarians, MD
Professor of Medicine
Leone-Perkins Family Endowed Chair in Cardiology
San Francisco Board Past-President, American Heart Association
Co-Director, Adult Cardiac Catheterization Laboratory
Director, Peripheral Interventional Cardiology Program
Director, Translational Cardiac Stem Cell Program
Cardiovascular Research Institute
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research
Associate Member in Experimental Therapeutics, UCSF Helen Diller Cancer Center
University of California, San Francisco
MedicalResearch.com: What is the background for this study?
Response: Obstructive sleep apnea is very common, undiagnosed and undertreated. The AHA Scientific Statement was prepared to increase awareness amongst physicians and patients about this condition and to encourage more screening and therapy as appropriate.
Obesity is certainly one of the significant risk factors for sleep apnea and we highlight this in the Scientific Statement:
“The risk of OSA correlates with body mass index, and obesity remains the one major modifiable
risk factor for OSA. In a population-based cohort study of 690 subjects, a 10% weight gain was associated with nearly 32% increase in the apnea-hypopnea index (AHI), and even modest weight control was effective in reducing the new occurrence of sleep-disordered breathing. An even stronger correlation exists between OSA and increased waist circumference and neck size.
Neck sizes predisposing to OSA are usually >17 and 16 in for men and women, respectively.”
Dr. Nation[/caption]
Daniel A. Nation, Ph.D.,
Associate Professor of Psychological Science
Institute for Memory Impairments and Neurological Disorders
University of California, Irvin
MedicalResearch.com: What is the background for this study?
Response: Hypertension is a risk factor for cognitive decline and dementia, and treatment of hypertension has been linked to decreased risk for cognitive impairment.
Prior studies have attempted to identify which specific type of antihypertensive treatment conveys the most benefit for cognition, but findings have been mixed regarding this question. We hypothesized that antihypertensive drugs acting on the brain angiotensin system may convey the greatest benefit since they affect the brain angiotensin system that has been implicated in memory function.
Dr. Seifi[/caption]
Ali Seifi, MD, FACP, FNCS, FCCM
Associate Professor
Director of Neuro Critical Care,
Fellowship Director, CAST Neurosurgery Critical Care
Department of Neurosurgery, Neurology, Anesthesiology and Medicine
The University of Texas Health Science Center at San Antonio
MedicalResearch.com: What is the background for this study?
Response: People get hiccups for several various reasons, most of the time is unknown etiology however the most known cause is when something is triggering the phrenic nerve which is a nerve that goes to the diaphragm and controls our breathing; as example any spicy food, alcoholic beverages, carbonated soda as well as eating fast can trigger this nerve.
So far, there has been no tool for treatment of hiccups instantly and this could be since the exact etiology of hiccups is still unknown and is multifactorial. Our aim was to make a feasible and easy for the public to use, a simple tool that anybody can use at home to get rid of hiccups . We patented and made the FISST, which is a tool that can stop hiccups instantly by distracting the nerves and muscles which are involved in causing hiccups. Hiccups is a vicious cycle between Phrenic nerve which contracts Diaphragm and Vagus nerve which contracts the Glottis and Epiglottis. Using FISST, requires intense activity of these two nerves and muscles for a few seconds, and thus it distracts the two nerve and muscles from the vicious cycle of triggers. We think because the FISST use the science behind all other remedies, but in union and under a pre-calculated required pressure and enough intensity, that can stops hiccups. All other home remedies work only on one of the mentioned 2 nerves or they cannot “Naturally “ generate the required enough intensity to stop the vicious cycle between the 2 nerves.
Dr. Conner[/caption]
Christopher Conner, MD, PhD
Neurosurgery resident
McGovern Medical School
The University of Texas Health Science Center at Houston
MedicalResearch.com: What is the background for this study?
Response: There has been a growing understanding in medicine that the incidence of motor vehicle trauma is changing. We have watched as Friday and Saturday night emergencies have declined without a good explanation. Several other studies have investigated this, but the results were not conclusive.
We think that is due to a lack of data from the rideshare companies and hospitals directly
Dr. Greco[/caption]
Giampaolo Greco PhD MPH
Assistant Professor
Department of Population Health Science and Policy
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study?
Response: The motivation for our study was to understand why mortality rate from breast cancer is much higher in African American women than in White women, despite the fact that these groups have similar incidence rate of breast cancer.
Metabolic syndrome, a cluster of metabolic abnormalities that includes abdominal obesity, hypertension, hyperglycemia and dyslipidemia, is more prevalent among African American women and may be a risk factor for breast cancer.
Subjective social status (SSS) is the perception of individuals of their own ranking in the social hierarchy and complements other parameters of socioeconomic status, such as income and education, that are considered more objective. Socioeconomic status is associated with cardiovascular and mental health. Although objective measures of social status are associated with worse breast cancer outcomes, the relationship of SSS to breast cancer is uncertain.
Dr. D'Amico[/caption]
Anthony D'Amico, MD, PhD
Professor and Chief of Genitourinary Radiation Oncology
Brigham and Women's Hospital and Dana-Farber Cancer Institute
MedicalResearch.com: What is the background for this study?
Response: 3 randomized trials published in Sept, 2020 in the Lancet and Lancet Oncology concluded that delivering radiation therapy (RT) after surgery for prostate cancer when the PSA rises signaling recurrence (i.e. early salvage RT) as opposed to when the PSA is undetectable (i.e. adjuvant RT) did not compromise subsequent cancer progression.
However these trials may have missed the benefit of adjuvant RT because a minority of men (9 to 17% of the study cohorts) were found to have adverse factors at prostatectomy which are associated with cancer progression and death from prostate cancer.
Specifically, men with adverse pathology at prostatectomy comprise the vast majority of men who go on to die from prostate cancer and therefore have the most to gain from adjuvant RT. Yet, given the results of the 3 randomized trials many physicians are no longer offering adjuvant RT, even in men with adverse pathology at surgery.
Dr. Chien-Wen Tseng[/caption]
Chien-Wen Tseng, M.D., M.P.H., M.S.E.E.
The Hawaii Medical Service Association Endowed Chair
Health Services and Quality Research
Professor, and Associate Research Director
Department of Family Medicine and Community Health
University of Hawaii John A. Burns School of Medicine
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Gaining weight during pregnancy is natural but gaining too little or too much weight can be harmful for pregnant people and their babies. For the first time, the Task Force reviewed the evidence and found that counseling pregnant people on healthy weight gain during pregnancy can lower their risk for diabetes during pregnancy, emergency cesarean deliveries, and babies born with a birth weight that is too high. Pregnant people may not know what amount of weight gain is healthy during pregnancy, or how weight gain can affect their pregnancy and baby.
We recommend that clinicians offer all pregnant people counseling on healthy weight gain throughout their pregnancy for healthier, safer pregnancies.
Dr. Kubik[/caption]
Martha Kubik, Ph.D., R.N.
Professor and Director
School of Nursing
College of Health and Human Services
George Mason University
MedicalResearch.com: What is the background for this study?
Response: Colorectal cancer is the third leading cause of cancer deaths in the United States, yet about a quarter of people ages 50 to 75 have never been screened for this devastating disease. Fortunately, we know that screening for colorectal cancer is effective and saves lives. New science about colorectal cancer in people younger than 50 years old has enabled us to expand our previous guidelines to recommend that all adults ages 45 to 75 be screened for colorectal cancer to reduce their risk of dying from this disease.
Dr. Whitlock[/caption]
Elizabeth L. Whitlock, MD, MSc
John W. Severinghaus Assistant Professor In Residence
Anesthesia & Perioperative Care
UCSF Medical Center
MedicalResearch.com: What is the background for this study?
Response: We have known for a while that, rarely, some older adults suffer substantial, durable cognitive decline after surgery, particularly after coronary artery bypass grafting (CABG) surgery; a larger proportion experience a decline in cognitive test performance which doesn't necessarily affect function, but which has caused concern among researchers. This cognitive decline was attributed, in part, to the cardiac bypass pump. Many of the studies had methodological limitations which made it difficult to be sure that the cognitive change was due to surgery and not due more generally to heart problems or atherosclerotic disease, which may also imply cerebrovascular atherosclerosis.
Using a large database of older adults who undergo regular cognitive testing, we identified individuals who underwent CABG and compared them to those who underwent percutaneous coronary intervention (PCI), a minimally invasive, non-surgical method of opening blocked coronary arteries. This allowed us to model the rate of memory decline before surgery - which hadn't been done in previous studies - and compare it to the rate of memory decline after surgery in older adults who had serious heart disease (some of whom were treated with CABG, and some treated with PCI).
Dr. Carlson[/caption]
Susan E. Carlson Ph.D.
Associate Dean for Research
Program Director,, AJ Rice Professor
Department of Dietetics and Nutrition
University of Kansas Medical Center
Kansas City, KS
MedicalResearch.com: What is the background for this study? What are its benefits?
Response: DHA is an omega-3 fatty acid. Good food sources include some types of seafood (e.g., salmon, tuna, trout) and chicken eggs. Persons in the USA and in much of the developing world consume little dietary DHA. DHA supplements in pregnancy have been linked to lower risk of preterm birth for 20 years, especially early preterm births (<34 weeks gestation). For about 10 years, prenatal supplements with about 200 mg DHA have been readily available in the USA, however, no study has asked if this amount of DHA is optimal to reduce early preterm birth. Participants were given a supplement of 1000 mg or 200 mg DHA beginning before 20 weeks gestation using an adaptive randomization that periodically assigned more participants to the group with the fewest early preterm births.
Dr. Garshick[/caption]
Michael S. Garshick, MD
Assistant Professor
Department of Medicine
Grossman School of Medicine
NYU
MedicalResearch.com: What is the background for this study?
Response: Patients with psoriasis have a 50% higher risk of cardiovascular disease when compared to patients without psoriasis, the mechanisms of which are still under investigation
Dyslipidemia is also highly prevalent in psoriasis including elevation in a variety of lipoproteins causal in atherosclerosis. Lipoprotein(a) is an LDL like particle which is associated with atherosclerosis, atherothrombosis, and the development of clinical cardiovascular disease. Traditionally lipoprotein(a) is felt to be inherited rather than acquired, but some evidence suggest that lipoprotein(a) is elevated in those with underlying inflammatory conditions and associated with systemic inflammation including circulating IL-6.
We therefore aimed to determine if lipoprotein(a) is elevated in psoriasis and associated with underlying systemic inflammatory profiles and biomarkers of cardiovascular risk.
Dr. Fuery[/caption]
Michael Fuery, MD
Department of Internal Medicine
Yale School of Medicine
[caption id="attachment_57307" align="alignleft" width="100"]
Dr. Clarke[/caption]
Katherine Clark, MD MBA
Division of Cardiovascular Medicine
Department of Internal Medicine
Yale School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Racial and ethnic disparities affect cardiac transplantation outcomes. In cohort analyses of racial and ethnic groups from the previous three decades, Black patients were constantly at a higher risk of mortality after cardiac transplantation. In 2018, the United Network for Organ Sharing (UNOS) revised the allocation system to expand access to organs for the most medically urgent patients and reduce disparities and regional differences. We sought to evaluate contemporary trends and impact of the new 2018 allocation system.
Dr. Ying Liu[/caption]
Ying Liu, MD, PhD
Assistant Professor
Washington University School of Medicine
Department of Surgery, Division of Public Health Sciences
St. Louis, MO
MedicalResearch.com: What is the background for this study?
Response: Non-Hispanic African American women experience a disproportional burden of poor breast cancer outcomes than non-Hispanic White women, which is associated with a higher incidence of triple-negative breast cancer (TNBC), more advanced stages at diagnosis, and lower treatment adherence. However, the differences in clinical treatment and outcomes between African American women with TNBC and their White counterparts have not been well defined.
Dr. Hagan[/caption]
Kobina Hagan MBBS, MPH Postdoctoral Fellow
Center for Outcomes Research,
Houston Methodist Research Institute
MedicalResearch.com: What is the background for this study?
Response: Before the COVID-19 vaccination roll-out, risk mitigation guidelines including respiratory hygiene, social distancing, and job flexibility, were the most effective preventive measures against coronavirus transmission. Social determinants of health scholarships had identified social circumstances to limit adherence to these mitigation guidelines. Individuals with underlying cardiovascular disease are identified as high-risk phenotypes for severe COVID-19 outcomes. In addition, research efforts during the early and middle waves of the pandemic had identified coronavirus exposure risk as a greater mediator of the observed COVID-19 disparities, compared to clinical susceptibility from comorbidities. Yet, population-based evidence on the practice of these mitigation guidelines in this high-risk group were lacking. Consequently, we believed there was a need to robustly characterize COVID-19 risk mitigation practices among adults with cardiovascular disease in the nation.
The COVID-19 Household Impact Survey was a survey conducted by the National Opinion Research Center at the University of Chicago, to provide statistics about health, economic security, and social dynamics of the US adult household population nationwide and for 18 geographic areas (10 states, 8 metropolitan statistical areas) between April and June 2020. This survey complemented the Household Pulse Survey by the Census Bureau.
In this study we described the COVID-19 risk mitigation practices among patients with CVD and evaluated the association between cumulative social determinants of health burden (a measure of social adversity) and adherence these measures.
Dr. Andersson[/caption]
Niklas Worm Andersson, MD
Department of Epidemiology Research
Statens Serum Institut,
Copenhagen Denmark
MedicalResearch.com: What is the background for this study?
Response: "Findings from some previous fetal safety studies on topical corticosteroid use in pregnancy have raised concerns for an increased risk of newborns being small for gestational age or having low birth weight, in particular among pregnancies where larger amounts of potent to very potent agents have been used."
Dr. Mezue[/caption]
Kenechukwu Ndubisi Mezue, M.D
Fellow in Nuclear Cardiology
Massachusetts General Hospital
MedicalResearch.com: What is the background for this study?
Response: Observational studies have shown that moderate alcohol intake may have beneficial effects on cardiovascular disease. However, the mechanisms through which this benefit occurs is mostly unknown. Chronic stress is also known to associate with increased risk of cardiovascular disease and our group has shown in previous work that increased activity in the stress-associated regions of the brain (such as the amygdala) is significantly associated with increased bone marrow activity, arterial inflammation, and cardiovascular events.
Our current study hypothesizes that moderate alcohol intake reduces cardiovascular events by reducing chronic stress-associated brain activity.
Dr. Wong[/caption]
John B. Wong, M.D.
Chief Scientific Officer
Vice chair for Clinical Affairs
Chief of the Division of Clinical Decision Making and
Primary care Clinician
Department of Medicine at Tufts Medical Center
MedicalResearch.com: What is the background for this study?
Response: Hypertension affects nearly half of all adults in the United States and is a major risk factor for many serious health conditions. Fortunately, by screening all adults for hypertension, clinicians can improve their patient’s health. The Task Force continues to recommend screening all adults for hypertension so that they can get the care they need to help prevent health conditions such as heart attack, stroke, and kidney failure.
Dr. Crandall[/caption]
Carolyn Crandall, M.D.
Professor, Medicine
Health Sciences Clinical Professor,
UCLA
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Previously-published studies had not examined in detail the risk of subsequent fractures after initial fractures in a large national sample of women in the us.
Clinical guidelines mostly emphasize initial hip and spine fractures, but they do not emphasize fractures of other types. We hypothesized that subsequent fracture risk would be higher after initial fracture even at locations other than the hip or the spine.